Autumn Labs vs Altria

Side-by-side comparison of AI visibility scores, market position, and capabilities

Altria leads in AI visibility (90 vs 29)

Autumn Labs

EmergingManufacturing

General

Autumn Labs develops AI systems for predictive maintenance and asset health monitoring in manufacturing and industrial environments, helping facilities reduce unplanned downtime.

AI VisibilityBeta
Overall Score
D29
Category Rank
#1053 of 1167
AI Consensus
62%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
25
Gemini
35

About

Autumn Labs is an industrial AI company focused on predictive maintenance and asset health monitoring for manufacturing facilities and industrial operators. Unplanned equipment downtime is one of the largest preventable costs in manufacturing—industry estimates put annual losses from unplanned downtime at hundreds of billions globally. Traditional preventive maintenance schedules service equipment at fixed intervals regardless of actual condition, often replacing parts that still have useful life while missing emerging failures between service events.

Full profile

Altria

LeaderConsumer Goods

Enterprise

Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.

AI VisibilityBeta
Overall Score
A90
Category Rank
#83 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
84
Perplexity
97
Gemini
99

About

Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.

Full profile

AI Visibility Head-to-Head

29
Overall Score
90
#1053
Category Rank
#83
62
AI Consensus
58
stable
Trend
stable
39
ChatGPT
84
25
Perplexity
97
35
Gemini
99
27
Claude
86
37
Grok
87

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.